Valuation Finch Therapeutics Group, Inc.

Stocks

Delayed OTC Markets 22:05:25 03/09/2026 +03			5-day change	1st Jan Change
10.35 ^USD	0.00%		0.00%	-23.26%

04-27	Acurx Pharmaceuticals, Inc., Adiso Therapeutics, Inc., Summit Therapeutics Inc., Finch Therapeutics Group, Inc. and Astrazeneca plc Announces Clostridium Difficile Infections Clinical Trial Updates	CI
03-26	Motion for Joint Administration Approved for Finch Therapeutics Group, Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	473.4	22.99	5.797
Change	-	-95.14%	-74.79%
Enterprise Value (EV) ¹	345.9	4.311	10.8
Change	-	-98.75%	150.5%
P/E	-6.72x	-0.2x	-0.08x
PBR	2.34x	0.24x	0.25x
PEG	0.1x	-0x	0x
Capitalization / Revenue	25.5x	26.7x	54.2x
EV / Revenue	18.7x	5.01x	101x
EV / EBITDA	-6x	-0.05x	-0.33x
EV / EBIT	-5.77x	-0.05x	-0.32x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-44.51	-72.12	-46.59
Distribution rate	-	-	-
Net sales ¹	18.53	0.861	0.107
EBITDA ¹	-57.68	-89.61	-32.48
EBIT ¹	-59.98	-95.12	-34
Net income ¹	-58.16	-114.6	-74.75
Net Debt ¹	-127.4	-18.68	5.002
Reference price ²	299.10	14.40	3.61
Nbr of stocks (in thousands)	1,583	1,597	1,606
Announcement Date	3/31/22 A	3/23/23 A	3/25/24 A

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
FINCH THERAPEUTICS GROUP, INC.	-	-	-	-	16.62M
LONZA GROUP AG	31.39x	5.65x	16.94x	1.03%	45.81B
REVOLUTION MEDICINES, INC.	-20.96x	242.19x	-22.49x	-.--%	43.91B
IQVIA HOLDINGS INC.	34.73x	3.34x	14.43x	-.--%	44.39B
BEONE MEDICINES AG	45.39x	5.23x	28.64x	-.--%	39.4B
CELLTRION, INC.	26.93x	8.12x	20.58x	0.42%	31.26B
MEDPACE HOLDINGS, INC.	35.28x	5.79x	26.31x	-.--%	17.32B
EUROFINS SCIENTIFIC SE	24.5x	2.13x	9.21x	1.09%	14.73B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	73x	3.87x	15.01x	-.--%	13.03B
Average	31.28x	34.54x	13.58x	0.32%	27.76B
Weighted average by Cap.	26.47x	46.77x	11.96x	0.31%